Open and minimally-invasive partial nephrectomy or thermal ablation for localized renal tumors in the United States: insurance claims data on perioperative outcomes and healthcare costs

TA is associated with significantly fewer complications and lower costs than PN. However, patients undergoing TA require re-operation more frequently, possibly due to higher recurrence rates. These factors need to be considered when selecting the most appropriate treatment for patients with renal tumors.

Authors

Institutions

Publication Details

Journal
Minerva Urology and Nephrology
Published
2025-10-01
DOI
https://doi.org/10.23736/s2724-6051.25.06447-x
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Open and minimally-invasive partial nephrectomy or thermal ablation for localized renal tumors in the United States: insurance claims data on perioperative outcomes and healthcare costs

Rajesh Nair, Ben J Challacombe, Wojciech Krajewski, Muhammad Shamim Khan et al.
Minerva Urology and Nephrology
Renal cell carcinoma treatment
article

Open and minimally-invasive partial nephrectomy or thermal ablation for localized renal tumors in the United States: insurance claims data on perioperative outcomes and healthcare costs

Rajesh Nair, Ben J Challacombe, Wojciech Krajewski, Muhammad Shamim Khan, Mohamed Hagazy, Aleksander Ślusarczyk, Francesco Porpiglia, Tomasz Szydełko, Wojciech Tomczak, Daniele Amparore, Felice Crocetto, Cristian Fiori, Mohammed E. Gad, Roman Mayr, Anas Tresh, Valerio Santarelli, Łukasz Nowak, Benjamin Inbeh Chung, Roberto Falabella, Shufeng Li, Francesco Del Giudice, Jan Łaszkiewicz, Matteo Ferro, Kim Hee Jung, Ramesh Thuraraja
article en

Abstract

TA is associated with significantly fewer complications and lower costs than PN. However, patients undergoing TA require re-operation more frequently, possibly due to higher recurrence rates. These factors need to be considered when selecting the most appropriate treatment for patients with renal tumors.

Minerva Urology and NephrologyVol. 77(5)
Guy's Hospital (GB), Guy's and St Thomas' NHS Foundation Trust (GB), Medical University of Warsaw (PL), Policlinico Umberto I (IT), Wroclaw Medical University (PL), Ospedale San Carlo (IT), Stanford Medicine (US), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Ospedale San Luigi Gonzaga (IT), Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo, Hanyang University (KR), University of Turin (IT), University of Regensburg (DE), European Institute of Oncology (IT), University of Naples Federico II (IT), Stanford University (US)
Openalex Percentile: Top 57%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.